Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension.

Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.

Enalapril and nifedipine in the treatment of mild to moderate essential hypertension: a 6 month comparison.

Spironolactone versus nifedipine in essential hypertension.

Combination of nifedipine and doxazosin in essential hypertension.

The safety and efficacy of terazosin in the treatment of essential hypertension in blacks.

Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina.

The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension.

Short-term efficacy and safety of a single five-milligram dose of oral nifedipine in uncontrolled essential systemic hypertension.

Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension.

Safety profile of benazepril in essential hypertension.

Long-term therapy with slow-release nifedipine in essential hypertension.

Chronic haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.

Acute haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.

Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r.

Long-term treatment of hypertension in the elderly with a combination of atenolol and nifedipine.

Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.

Efficacy and safety of carvedilol in renal hypertension. A multicenter open trial.

Co-dergocrine mesylate inhibits the increase in plasma catecholamines caused by nifedipine in essential hypertension.

A comparison of the safety of therapeutically equivalent doses of isradipine and diltiazem for treatment of essential hypertension.

Successful treatment of acute postoperative pulmonary hypertension with nifedipine.

Combined use of nifedipine and diltiazem for the treatment of severe hypertension.

Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Effect of nifedipine on fetal heart rate in the treatment of severe pregnancy-induced hypertension.

A physiological basis for the treatment of essential hypertension.

Suggest Documents

Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus.

Enalapril and nifedipine in the treatment of mild to moderate essential hypertension: a 6 month comparison.

Spironolactone versus nifedipine in essential hypertension.

Combination of nifedipine and doxazosin in essential hypertension.

The safety and efficacy of terazosin in the treatment of essential hypertension in blacks.

Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina.

The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension.

Short-term efficacy and safety of a single five-milligram dose of oral nifedipine in uncontrolled essential systemic hypertension.

Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension.

Safety profile of benazepril in essential hypertension.

Long-term therapy with slow-release nifedipine in essential hypertension.

Chronic haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.

Acute haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.

Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r.

Long-term treatment of hypertension in the elderly with a combination of atenolol and nifedipine.

Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.

Efficacy and safety of carvedilol in renal hypertension. A multicenter open trial.

Co-dergocrine mesylate inhibits the increase in plasma catecholamines caused by nifedipine in essential hypertension.

A comparison of the safety of therapeutically equivalent doses of isradipine and diltiazem for treatment of essential hypertension.

Successful treatment of acute postoperative pulmonary hypertension with nifedipine.

Combined use of nifedipine and diltiazem for the treatment of severe hypertension.

Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Effect of nifedipine on fetal heart rate in the treatment of severe pregnancy-induced hypertension.

A physiological basis for the treatment of essential hypertension.

Safety of the coadministration of carvedilol and nifedipine sustained-release in the treatment of essential hypertension.

Recommend Documents

Follow Us